The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Drug Resistance in Leishmaniasis
Open accessAbstract
SUMMARY: Leishmaniasis is a complex disease, with visceral and cutaneous manifestations, and is caused by over 15 different species of the protozoan parasite genus Leishmania. There are significant differences in the sensitivity of these species both to the standard drugs, for example, pentavalent antimonials and miltefosine, and those on clinical trial, for example, paromomycin. Over 60% of patients with visceral leishmaniasis in Bihar State, India, do not respond to treatment with pentavalent antimonials. This is now considered to be due to acquired resistance. Although this class of drugs has been used for over 60 years for leishmaniasis treatment, it is only in the past 2 years that the mechanisms of action and resistance have been identified, related to drug metabolism, thiol metabolism, and drug efflux. With the introduction of new therapies, including miltefosine in 2002 and paromomycin in 2005-2006, it is essential that there be a strategy to prevent the emergence of resistance to new drugs; combination therapy, monitoring of therapy, and improved diagnostics could play an essential role in this strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785
Cytochrome C -Mediated Apoptosis
Jiang, X., & Wang, X. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073706 · Cited by 1,357
The increase in risk factors for leishmaniasis worldwide
Desjeux, P. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90223-8 · Cited by 1,043
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
Croft, S. L., & Coombs, G. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.008 · Cited by 891
Self-citationOral Miltefosine for Indian Visceral Leishmaniasis
Sundar, S., Jha, T. K., Thakur, C. P., Engel, J., Sindermann, H., Fischer, C., Junge, K., Bryceson, A., & Berman, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021556 · Cited by 779
Self-citationLeishmania and human immunodeficiency virus coinfection: the first 10 years
Alvar, J., Cañavate, C., Gutiérrez-Solar, B., Jiménez, M., Laguna, F., López-Vélez, R., Molina, R., & Moreno, J. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.2.298 · Cited by 736
Sundar, S., More, D. K., Singh, M. K., Singh, V. P., Sharma, S., Makharia, A., Kumar, P. C. K., & Murray, H. W. (2000) · Clinical Infectious Diseases · doi:10.1086/318121 · Cited by 664
Self-citationLevin, B. R., Perrot, V., & Walker, N. (2000) · Genetics · doi:10.1093/genetics/154.3.985 · Cited by 624
Drug resistance in Indian visceral leishmaniasis
Sundar, S. (2001) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2001.00778.x · Cited by 585
Self-citationAmphotericin B: spectrum and resistance
Ellis, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.7 · Cited by 473
Injectable Paromomycin for Visceral Leishmaniasis in India
Sundar, S., Jha, T. K., Thakur, C. P., Sinha, P. K., & Bhattacharya, S. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066536 · Cited by 471
Self-citationEffects of Environment on Compensatory Mutations to Ameliorate Costs of Antibiotic Resistance
Björkman, J., Nagaev, I., Berg, O. G., Hughes, D., & Andersson, D. I. (2000) · Science · doi:10.1126/science.287.5457.1479 · Cited by 452
Bacterial resistance to aminoglycoside antibiotics
Davies, J., & Wright, G. D. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01033-0 · Cited by 403
Leishmania/HIV co-infections: epidemiology in Europe
Desjeux, P., & Alvar, J. (2003) · Annals of Tropical Medicine & Parasitology · doi:10.1179/000349803225002499 · Cited by 398
Miltefosine for New World Cutaneous Leishmaniasis
Soto, J., Arana, B. A., Toledo, J., Rizzo, N., Vega, J. C., Diaz, A., Luz, M., Gutierrez, P., Arboleda, M., Berman, J. D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/383321 · Cited by 385
Croft, S., & Yardley, V. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023396258 · Cited by 380
Self-citationVisceral Infection Caused by Leishmania tropica in Veterans of Operation Desert Storm
Magill, A. J., Grogl, M., Gasser, R. A., Sun, W., & Oster, C. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281904 · Cited by 369
Leishmaniasis: new approaches to disease control
Davies, C. R., Kaye, P., Croft, S. L., & Sundar, S. (2003) · BMJ · doi:10.1136/bmj.326.7385.377 · Cited by 303
Self-citationRoberts, C. W., McLeod, R., Rice, D. W., Ginger, M., Chance, M. L., & Goad, L. J. (2003) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(02)00280-3 · Cited by 296
Meyerhoff, A. (1999) · Clinical Infectious Diseases · doi:10.1086/515085 · Cited by 295
Molecular mechanisms of drug resistance
Hayes, J. D., & Wolf, C. R. (1990) · Biochemical Journal · doi:10.1042/bj2720281 · Cited by 279
Pentamidine uptake and resistance in pathogenic protozoa: past, present and future
Bray, P. G., Barrett, M. P., Ward, S. A., & de Koning, H. P. (2003) · Trends in Parasitology · doi:10.1016/s1471-4922(03)00069-2 · Cited by 261
The Leishmania ATP-binding Cassette Protein PGPA Is an Intracellular Metal-Thiol Transporter ATPase
Légaré, D., Richard, D., Mukhopadhyay, R., Stierhof, Y.-D., Rosen, B. P., Haimeur, A., Papadopoulou, B., & Ouellette, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102351200 · Cited by 242
Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.
Mukhopadhyay, R., Dey, S., Xu, N., Gage, D., Lightbody, J., Ouellette, M., & Rosen, B. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10383 · Cited by 238
Population Biology, Evolution, and Infectious Disease: Convergence and Synthesis
Levin, B. R., Lipsitch, M., & Bonhoeffer, S. (1999) · Science · doi:10.1126/science.283.5403.806 · Cited by 234
Heavy metal resistance: a new role for P-glycoproteins in Leishmania.
Callahan, H. L., & Beverley, S. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55077-8 · Cited by 226
Molecular mechanisms of antimony resistance in Leishmania
Ashutosh, Sundar, S., & Goyal, N. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46841-0 · Cited by 222
Self-citationHomolya, L., Váradi, A., & Sarkadi, B. (2003) · BioFactors · doi:10.1002/biof.5520170111 · Cited by 208
In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs
Seifert, K., & Croft, S. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.73-79.2006 · Cited by 207
Self-citationBasselin, M., Denise, H., Coombs, G. H., & Barrett, M. P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3731-3738.2002 · Cited by 195
Ovothiol and trypanothione as antioxidants in trypanosomatids
Ariyanayagam, M. (2001) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00285-7 · Cited by 192
Arevalo, I., Ward, B., Miller, R., Meng, T., Najar, E., Alvarez, E., Matlashewski, G., & Llanos‐Cuentas, A. (2001) · Clinical Infectious Diseases · doi:10.1086/324161 · Cited by 189
Grondin, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3057 · Cited by 188
Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae
Young, L. Y., Hull, C. M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2717-2724.2003 · Cited by 186
Collin, S., Davidson, R., Ritmeijer, K., Keus, K., Melaku, Y., Kipngetich, S., & Davies, C. (2004) · Clinical Infectious Diseases · doi:10.1086/381203 · Cited by 180
Chunge, C. N., Owate, J., Pamba, H. O., & Donno, L. (1990) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(90)90263-e · Cited by 175
Berman, J. D., Badaró, R. J. D. S., Thakur, C. P., Wasunna, K. M., Behbehani, K., Davidson, R. N., Kuzoe, F. A. S., Pang, L. W., Weerasuriya, K., & Bryceson, A. D. M. (1998) · Europe PMC (PubMed Central) · Cited by 171
Leishmania in discarded syringes from intravenous drug users
Cruz, I., Morales, M., Noguer, I., Rodriguez, A., & Alvar, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08160-6 · Cited by 171
Sudhandiran, G., & Shaha, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301975200 · Cited by 168
Zhou, Y., Messier, N., Ouellette, M., Rosen, B. P., & Mukhopadhyay, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404383200 · Cited by 161
The de novo selection of drug–resistant malaria parasites
White, N. J., & Pongtavornpinyo, W. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2002.2241 · Cited by 158
DENTON, H., McGregor, J. C., & Coombs, G. H. (2004) · Biochemical Journal · doi:10.1042/bj20040283 · Cited by 155
A PHASE II DOSE-INCREASING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN KENYA
Wasunna, M. K., RASHID, J. R., Mbui, J., Kirigi, G., Kinoti, D., Lodenyo, H. A., Felton, J. M., SABIN, A. J., & HORTON, J. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.871 · Cited by 150
A Revised Classification for Leishmania and Endotrypanum
Cupolillo, E., Medina‐Acosta, E., Noyes, H. A., Momen, H., & Grimaldi, G. (2000) · Parasitology Today · doi:10.1016/s0169-4758(99)01609-9 · Cited by 145
Herman, J. D., Gallalee, J. V., & Best, J. M. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90689-7 · Cited by 140
Pérez-Victoria, J. M., Pérez‐Victoria, F. J., Parodi‐Talice, A., Jiménez, I. A., Ravelo, Á. G., Castanys, S., & Gamarro, F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2468-2474.2001 · Cited by 140
Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes
Beach, D. H., Goad, L. J., & Holz, G. G. (1988) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(88)90166-1 · Cited by 139
Addy, M., & Nandy, A. (1992) · Europe PMC (PubMed Central) · Cited by 135
Antibiotic resistance surveillance: action for international studies
Morris, A. K., & Masterton, R. G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.7 · Cited by 135
Sundar, S., Jha, T. K., Thakur, C. P., Mishra, M., Singh, V. P., & Buffels, R. (2003) · Clinical Infectious Diseases · doi:10.1086/377542 · Cited by 134
Self-citationKelly, S. L., Lamb, D. C., Taylor, M., Corran, A. J., Baldwin, B. C., & Powderly, W. G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07140.x · Cited by 133
HIV and the transmission ofLeishmania
Molina, R., Gradoni, L., & Alvar, J. (2003) · Annals of Tropical Medicine and Parasitology · doi:10.1179/000349803225002516 · Cited by 132
Pharmacokinetics and pharmacology of terbinafine and itraconazole
Leyden, J. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70483-9 · Cited by 129
Haimeur, A., Guimond, C., Pilote, S., Mukhopadhyay, R., Rosen, B. P., Poulin, R., & Ouellette, M. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01634.x · Cited by 127
CHARACTERIZATION OF NATURAL ANTIMONY RESISTANCE IN LEISHMANIA DONOVANI ISOLATES
Mittal, M. K., Rai, S., Ashutosh, A., et al. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.76.681 · Cited by 126
GRAMICCIA, M., Gradoni, L., & Orsini, S. (1992) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1992.11812717 · Cited by 121
Guimond, C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg806 · Cited by 118
Response to Interferon‐γ plus Pentavalent Antimony in Indian Visceral Leishmaniasis
Sundar, S., Singh, V. P., Sharma, S., Makharia, M. K., & Murray, H. W. (1997) · The Journal of Infectious Diseases · doi:10.1086/516526 · Cited by 116
Self-citationIn VivoInterference of Paromomycin with Mitochondrial Activity ofLeishmania
Maarouf, M., de Kouchkovsky, Y., Brown, S., Petit, P. X., & Robert-Géro, M. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3500 · Cited by 113
A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis
Koutinas, A. F., Saridomichelakis, M. N., Mylonakis, M. E., Leontides, L., Polizopoulou, Z. S., Billinis, C., Argyriadis, D., Diakou, Α., & Papadopoulos, O. (2001) · Veterinary Parasitology · doi:10.1016/s0304-4017(01)00399-5 · Cited by 112
Interaction of antimony tartrate with the tripeptide glutathione
Sun, H., Yan, S., & Cheng, W. S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01605.x · Cited by 103
A PHASE II DOSE-RANGING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN INDIA
JHA, T. K., SUNDAR, S., THAKUR, C. P., Felton, J. M., SABIN, A. J., & HORTON, J. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.1005 · Cited by 103
Self-citationThakur, C. P., Kumar, M., Kumar, P., Mishra, B. N., & Pandey, A. K. (1988) · BMJ · doi:10.1136/bmj.296.6636.1557 · Cited by 99
pH homeostasis in Leishmania donovani amastigotes and promastigotes.
Glaser, T. A., Baatz, J. E., Kreishman, G. P., & Mukkada, A. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7602 · Cited by 98
Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.
Sundar, S., Jha, T. K., Thakur, C. P., Mishra, M., Singh, V., & Buffels, R. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.66.143 · Cited by 98
Self-citationDrug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania
Ouellette, M., & Borst, P. (1991) · Research in Microbiology · doi:10.1016/0923-2508(91)90089-s · Cited by 97
Free radical metabolism of antiparasitic agents.
Docampo, R., & Moreno, S. N. J. (1986) · PubMed · Cited by 93
Pourshafie, M. R., Morand, S. C., Virion, A., Rakotomanga, M., Dupuy, C., & Loiseau, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2409-2414.2004 · Cited by 85
Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial.
Sn, J., Singh, N. K., & Tk, J. (1991) · PubMed · Cited by 85
Induction of Resistance to Azole Drugs in Trypanosoma cruzi
C, F. S. B. A., Wilson, A. J., White, T. C., & Voorhis, W. C. V. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3245 · Cited by 84
Soto, J., Toledo, J. T., Gutiérrez, P., Arboleda, M., Nicholls, R. S., Padilla, J. C., Berman, J. D., English, C. K., & Grögl, M. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.66.147 · Cited by 81
Wyllie, S., & Fairlamb, A. H. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.043 · Cited by 76
Self-citationVisceral Leishmaniasis Treatment, Italy
Gradoni, L., GRAMICCIA, M., & Scalone, A. (2003) · Emerging infectious diseases · doi:10.3201/eid0912.030178 · Cited by 76
Comparison of regimens of treatment with sodium stibogluconate in kala-azar.
Thakur, C. P., Kumar, M., Singh, S. K., Sharma, D., Prasad, U., Singh, R. S., Dhawan, P. S., & Achari, V. (1984) · BMJ · doi:10.1136/bmj.288.6421.895 · Cited by 73
Laguna, F., Videla, S., Me, J.-M., Sirera, G., Torre-Cisneros, J., Ribera, E., Prados, D., Clotet, B., Sust, M., López-Vélez, R., et al. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg356 · Cited by 72
Trypanothione S-Transferase Activity in a Trypanosomatid Ribosomal Elongation Factor 1B
Vickers, T. J., & Fairlamb, A. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311039200 · Cited by 63
Self-citationGiorgio, C. D., Faraut-Gambarelli, F., Imbert, A., Minodier, P., Gasquet, M., & Dumon, H. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.1.71 · Cited by 63
Carrió, J., & Portús, M. (2002) · BMC Pharmacology · doi:10.1186/1471-2210-2-11 · Cited by 56
Rangel, H. R., Dagger, F., Hernández, Á. G., Liendo, A., & Urbina, J. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2785 · Cited by 55
Glutathione S-transferase π in an arsenic-resistant Chinese hamster ovary cell line
Lo, J. F., Wang, H. F., Tam, M. F., & Lee, T. (1992) · Biochemical Journal · doi:10.1042/bj2880977 · Cited by 54
Further evidence that deltamethrin‐impregnated collars protect domestic dogs from sandfly bites
Halbig, P., Hodjati, M. H., Gavgani, A. M., Mohite, H., & Davies, C. R. (2000) · Medical and Veterinary Entomology · doi:10.1046/j.1365-2915.2000.00229.x · Cited by 51
Pentamidine-induced diabetes mellitus
Jha, T. K., & Sharma, V. K. (1984) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(84)90289-x · Cited by 49
Gene Amplification in Amphotericin B-Resistant Leishmania tarentolae
Singh, A. K., Papadopoulou, B., & Ouellette, M. (2001) · Experimental Parasitology · doi:10.1006/expr.2001.4663 · Cited by 44
Cited by
Reithinger, R., Dujardin, J.-C., Louzir, H., Pirmez, C., Alexander, B., & Brooker, S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70209-8 · Cited by 1,334
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Ponte-Sucre, A., Gamarro, F., Dujardin, J.-C., Barrett, M. P., López-Vélez, R., García-Hernández, R., Pountain, A. W., Mwenechanya, R., & Papadopoulou, B. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0006052 · Cited by 962
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Cañavate, C., Dedet, J.-P., Gradoni, L., Ter Horst, R., López-Vélez, R., & Moreno, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-07 · Cited by 937
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
Baneth, G., Koutinas, A. F., Solano-Gallego, L., Bourdeau, P., & Ferrer, L. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.04.001 · Cited by 708
Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis
Solano-Gallego, L., Koutinas, A., Miró, G., Cardoso, L., Pennisi, M. G., Ferrer, L., Bourdeau, P., Oliva, G., & Baneth, G. (2009) · Veterinary Parasitology · doi:10.1016/j.vetpar.2009.05.022 · Cited by 622
Metadata
- Authors
- Croft, S. L., Sundar, S., & Fairlamb, A. H.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2006-01
- Volume
- 19
- Issue
- 1
- Pages
- 111-126
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1963542761
- Cited by
- 1,663
- References
- 84
- FWCI
- 64.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.